NBI – NASDAQ BIOTECH
​Despite a devastating decline of -35% per cent from the July ’15 high of 4194.87, the Nasdaq Biotechnology index (NBI) is approaching a major low, finalising this decline towards current levels of 2714.11 and idealised Fibonacci-Price-Ratio (FPR) measurements at 2681.36+/. However, there are indications that the NBI is now in the early stages of resuming its medium-term uptrend.
WaveTrack International provides bespoke intelligence for Asset Management Corporations, Pension Funds, Total/Absolute-Return/ Hedge Funds, Sovereign Wealth Funds, Corporate and Market-Making/Trading institutions. The ‘deterministic’ qualities of the methodology used often translates into results that are dynamic and – outside consensus estimates. This is suitable for individuals who seek unbiased market research which is ‘technical, quantitative and strategic’ for their investment decision making. WaveTrack’s analysis and research is especially relevant for medium/long-term investment strategies.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.